MSTATT LLC
Medical Sensing, Testing, and Therapeutic Technologies)

We commercialize novel applications for cutting edge photonic and biochemical technologies.


  • We are a team of technical and commercialization experts who are applying cutting edge technologies to real-world problems.

  • We are experts in optics, biochemical processes, optical coherence tomography, and Brillouin Spectrometry

  • We are working across a number of industries, including dental devices, medical devices, industrial coatings, and chemical processing.



News:

January 2020: Received NSF SBIR Phase I funding for our patent-pending Brillouin spectrometer system promises to transform dentistry by enabling early-stage caries detection. Early detection enables early treatment, precluding the need for cavity drilling or other surgical interventions. We are able to detect caries earlier and more effectively than other methods.